This story was co-published with Stat. It’s a promising new drug for multiple myeloma, one of the most savage blood cancers. Called Ninlaro, it can be taken as a pill, sparing patients painful injections or cumbersome IV treatments. In a video sponsored by the manufacturer, Takeda Pharmaceutical Co., one patient even hailed Ninlaro as “my
黑人患者在有希望的癌症药物上失踪
ProPublica分析发现,黑人和美洲原住民在新药临床试验中的代表性不足,即使治疗针对的是一种对其影响不成比例的癌症。